Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001437749-22-028468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-05 | 2022-12-02 | LMAT | Jasinski Lawrence J | Dir | M - OptEx | $33.41 | +10.0K | 11.4K | +710% | +$334.1K |
| D | 2022-12-05 | 2022-12-02 | LMAT | Jasinski Lawrence J | Dir | S - Sale+OE | $47.07 | -10.0K | 8,909 | -53% | -$470.7K |
| DM | 2022-12-05 | 2022-12-02 | LMAT | Jasinski Lawrence J | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
| D | 2022-12-05 | 2022-12-01 | LMAT | Jasinski Lawrence J | Dir | A - Grant | $0.00 | +1.53 | 4.53 | +51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | M | A | 5,000 | $37.29 | 18,909 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2022-12-02 | S | D | 10,000 | $47.07 | 8,909 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.00 to $47.23. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-12-02 | M | A | 2,500 | $35.48 | 13,909 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 4 | Common | Common Stock | 2022-12-02 | M | A | 2,500 | $23.56 | 11,409 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-12-02 | M | D | 5,000 | $0.00 | 2,500 | D | $37.29 · 2020-12-02 to 2025-12-02 | 5,000 Common Stock | (F5) This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-12-02 | M | D | 2,500 | $0.00 | 2,500 | D | $35.48 · 2019-12-20 to 2024-12-20 | 2,500 Common Stock | (F5) This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-12-02 | M | D | 2,500 | $0.00 | 0 | D | $23.56 · 2018-12-19 to 2023-12-19 | 2,500 Common Stock | (F4) This option is fully vested and exercisable. |
| 8 | Derivative | Dividend Equivalent Rights | 2022-12-01 | A | A | 1.53 | $0.00 | 4.53 | D | — · — to — | 1.53 Common Stock | (F3) These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |